Separate monthly billing, shipment intervals and prepaid discounts before comparing this compounded program.
- Listed monthly price
- $297
- Six months paid in full
- $1,482 in published terms
- Document date
- December 3, 2025; rechecked October 10, 2026
What the published schedule establishes
The Henry Meds terms page lists compounded semaglutide injections at $297 per month and describes alternative fulfillment intervals of 70 or 90 days. That means the billing period and shipment interval should not be treated as synonyms. Ask which current supply arrangement the clinician and pharmacy would use for the prescription actually offered.[source]
We checked the page in October 2026, but its stated update date is December 2025. That older document date matters for a purchase decision. The numbers here are a reading of published terms; we have not completed intake or verified that each listed arrangement remains available in every served state.
The discount buys a longer commitment
The listed six-month paid-in-full amount is $1,482, compared with $1,782 for six payments at $297. The difference is $300 under those published assumptions. Twelve months paid in full is listed at $2,364, a $197 monthly equivalent. The amount at risk if circumstances change is different from the monthly plan.[source]
Get the refund rule for unused treatment and future shipments in writing. A six-month purchase need not mean all medicine ships together, and an installment arrangement need not mean the service can be canceled without a remaining obligation. The quote and contract should settle those points.
Confirm route and clinical need
Henry’s sublingual listings are separate programs. Their prices and quantities do not belong in an injection calculation. FDA-approved semaglutide evidence also cannot be assumed to validate every compounded formulation or route. FDA recommends compounded GLP-1 drugs only where an approved medicine cannot meet the patient’s needs.[source]
Before paying, identify the dispensing pharmacy, included supplies and the clinician contact for side-effect or instruction questions. This review supplies a purchasing framework, not an assessment of your suitability or a recommendation to change medication.
A supply question worth asking before a long commitment
The terms describe quantities and shipment intervals, but those do not establish how many usable doses a particular prescription will provide. The actual concentration, prescribed directions and storage limits matter. Have the dispensing pharmacy explain the label and the plan for subsequent shipments; do not calculate a personal dosing schedule from the amount listed in a commercial program description.
A price per milligram can look precise while hiding differences in route, concentration, supplies and clinical service. This review therefore compares published program charges and commitments. It does not convert them into a self-directed dose or claim that a larger supply is better value for every patient.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- Henry Meds: program terms and supply periodsTerms page checked October 10, 2026; page itself dated December 3, 2025. Availability must be confirmed. · Checked October 10, 2026
- FDA: concerns with unapproved GLP-1 drugsCompounded-product risks, salt forms, dosing errors and online red flags · Checked October 10, 2026